New competency framework for Parkinson’s nurses

The third edition of the competency framework for Parkinson’s nurses is now available following work led by the Parkinson’s Disease Nurse Specialist Association (PDNSA) in collaboration with the Royal College of Nursing and the UK Parkinson’s Excellence Network.

This revised competency framework describes the competencies (in terms of knowledge, education and skills) required by specialist nurses to provide safe and effective care for people with Parkinson’s.

Continue reading

From MasterClass to Chair of Psychiatry

by Dr Peter Fletcher

One of the many joys of having been the Parkinson’s Academy’s Academic Director since we began our MasterClasses in 2002 is that I have read every single needs analysis questionnaire submitted by our participants – 100s and 100s of them! What talent we have passing through our MasterClases, with what I see in the questionnaires translated into three-dimensional reality both during the MasterClasses and in terms of what happens next.

Continue reading

What do people with Parkinson’s want, what do they need and do health care professionals actually know?

by Dr Peter Fletcher

One of the joys of the World Parkinson’s Congress (WPC) is meeting people with Parkinson’s (pwp) and their families, carers and significant others. The 4th WPC in September 2016 drew participants from all over the world but specifically it was a huge opportunity to speak with so many from the USA and Canada perhaps not surprising as we were in Portland Oregon.

Continue reading

A celebration of the 200th anniversary of the publication of James Parkinson’s “Essay on the Shaking Palsy”

James Parkinson’s “An Essay on the Shaking Palsy” was published in 1817 and described the condition that would eventually bear his name. Approximately 127,000 people in the UK are affected by Parkinson’s disease (PD).

The Royal College of Physicians of Edinburgh is holding a two-day symposium which will cover the management of motor and non-motor complications of PD, updates on the latest scientific developments and the important role of multidisciplinary teams in caring for people with PD. Continue reading

Promotional meeting report: Extending choice in Parkinson’s disease by Profile pharma Ltd

Profile Pharma have paid for and placed this article

Xadago (safinamide) Prescribing Information

Extending Choice in Parkinson’s Disease was a one-day meeting organised by Profile Pharma (a subsidiary of Zambon SpA), held in December 2016 in London.  Chaired by Dr Peter Fletcher from the Gloucestershire Hospitals NHS Foundation Trust and Prof Andrew Lees from The National Hospital for Neurology and Neurosurgery, London, it brought together 161 specialists from all aspects of Parkinson’s Disease (PD) care for a day of engaging and informative discussion covering the entire patient journey from diagnosis to end-of-life care. Continue reading